Cell Banking Outsourcing Market Overview
The global cell banking outsourcing market is undergoing transformative growth, with market size reaching USD 12.5 billion in 2023 and projected to soar to USD 49.9 billion by 2032, registering a robust CAGR of 16.6% during the forecast period from 2024 to 2032. This acceleration is driven by increasing demand for biopharmaceuticals, stem cell-based therapeutics, and the growing need for standardized and regulatory-compliant storage of cell lines.
Outsourcing cell banking services has become a cornerstone strategy for biotechnology and pharmaceutical companies aiming to reduce operational complexity, comply with stringent regulatory guidelines, and accelerate the time-to-market of novel therapies. With rising investments in regenerative medicine, advanced biologics, and personalized therapies, the market continues to experience rapid evolution and expansion.
Get a Free Sample Report of Cell Banking Outsourcing Market@ https://www.snsinsider.com/sample-request/2836
Cell Banking Outsourcing Market Growth Drivers:
The cell banking outsourcing market is propelled by several critical factors. One of the foremost drivers is the growing reliance on master cell banking for ensuring product consistency and regulatory compliance in biopharmaceutical production. The U.S. FDA’s guidelines emphasize the need for well-characterized master cell banks in Investigational New Drug (IND) applications for gene therapies, reinforcing their indispensable role in ensuring the safety and efficacy of biotherapeutic products.
Advancements in stem cell research are another vital force fueling market growth. According to the National Institutes of Health (NIH), federal funding for stem cell research hit USD 2.1 billion in FY2024, reflecting a 12% increase over the previous year. This investment is enabling more robust pipelines in stem cell-based clinical trials, which have increased by 22% annually since 2020, driving demand for secure and scalable cell banking services.
The expansion of cryogenic storage infrastructure is further supporting market growth. As per the National Institute of Standards and Technology (NIST), the demand for long-term biological sample preservation has climbed 28% since 2020. In response, there has been a 33% increase in investments in advanced storage and preservation technologies, enhancing the value proposition of outsourced banking services. Regulatory emphasis from agencies like the FDA and CDC on container integrity and cell viability during storage is pushing biopharma companies toward high-quality, compliant storage solutions.
Cell Banking Outsourcing Market Segment Insights:
By Type, master cell banking emerged as the leading segment in 2023, capturing 63% of the global market share. This segment’s dominance stems from its role in producing reliable and genetically stable cell lines for biologics manufacturing. With regulatory authorities endorsing master cell bank-derived products, the number of Biologics License Applications (BLAs) submitted and approved continues to grow, with an 18% year-on-year increase, signaling strong demand and validation of this approach.
The cost-effectiveness of master cell banking also boosts its adoption. As estimated by the National Cancer Institute (NCI), using master banks can cut down development costs by up to 40%, a compelling proposition for biomanufacturers aiming to reduce time and capital expenditure.
By Cell Type, the stem cells segment held the largest revenue share in 2023 at 53%. This dominance is attributed to expanding applications in treating hematological, neurological, and autoimmune disorders. In fact, stem cell transplants have grown 35% in the past five years, according to the U.S. Department of Health and Human Services (HHS). Scientific output in the field, particularly on induced pluripotent stem cells (iPSCs), has also surged, with a 40% increase in publications since 2021.
As of January 2025, the FDA granted Regenerative Medicine Advanced Therapy (RMAT) designation to 45 stem cell-based products, reinforcing their clinical relevance and contributing significantly to the segment’s market leadership.
By Phase, bank storage represented the largest segment in 2023, commanding 42% of the global market. Biopharma organizations and research institutes are increasingly recognizing the importance of secure, long-term storage. Guidance from the FDA on biologics packaging has prompted a 20% increase in adoption of automated cryopreservation systems. Enhanced storage facilities not only support compliance but also extend the shelf life of cell lines to over 25 years, as reported by the CDC, offering long-term returns on infrastructure investments.
Regional Outlook:
North America remained the leading regional market in 2023, accounting for 45% of the global revenue. The region benefits from a robust biopharmaceutical ecosystem, a high number of cell-based therapy developers, and strong regulatory and funding support. According to the FDA, BLAs for cell-based products grew 30% annually since 2020, while the NIH allocated USD 3.2 billion in FY2024 to regenerative medicine research—a 15% increase from the previous year.
Meanwhile, Asia-Pacific is set to grow at the fastest pace between 2024 and 2032. This growth is underpinned by rising governmental support, increased clinical trial activities, and biomanufacturing expansions in countries like China, India, and Japan. The China National Center for Biotechnology Development reports a 25% annual rise in funding for cell therapy research since 2021, while Japan has seen a doubling of regenerative medicine product approvals over the last three years, indicating a growing maturity in the market.
Need Any Customization Research on Cell Banking Outsourcing Market, Enquire Now@ https://www.snsinsider.com/enquiry/2836
Recent Developments:
The market is witnessing a wave of innovation. In January 2024, Cellply Srl introduced VivaCyte, an automated single-cell potency characterization platform to support cellular immunotherapy development. In April 2023, BioOutsource Ltd. launched a biosimilars characterization service, enhancing offerings for monoclonal antibody producers. Meanwhile, panCELLa’s collaboration with BioCentriq in May 2023 focuses on enhancing NK cell potency using genetically engineered iPSC-derived feeder cells—underscoring the synergy between advanced research and commercial scalability.
Key Players:
The competitive landscape is populated by prominent players such as Charles River Laboratories, Lonza Group, WuXi AppTec, Merck KGaA, Cryo-Cell International, and SGS Life Sciences. These companies are setting industry standards in areas such as GMP-compliant cell banking, cell line characterization, viral safety testing, and advanced media development. Other key stakeholders include Pfizer, Novartis, Johnson & Johnson, Roche, and AstraZeneca, which rely heavily on outsourcing partnerships for efficient cell line management and biomanufacturing scalability.
As biopharmaceutical development accelerates globally, the cell banking outsourcing market stands at the forefront of supporting next-generation therapeutics. Its integral role in gene and cell therapy pipelines, coupled with technological advancements in cryopreservation, stem cell biology, and regulatory harmonization, will continue to drive robust expansion over the coming decade. Stakeholders investing in innovation, quality assurance, and infrastructure development are well-positioned to capitalize on the extraordinary growth trajectory of this critical segment of the life sciences industry.
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
6. Competitive Landscape
7. Cell Banking Outsourcing Market by Type
8. Cell Banking Outsourcing Market by Phase
9. Cell Banking Outsourcing Market by Cell Type
10. Regional Analysis
11. Company Profiles
12. Use Cases and Best Practices
13. Conclusion
Read Our Other Report
Microneedle Drug Delivery Systems Market
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Jagney Dave – Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: [email protected]
